Efficacy of neoadjuvant endocrine therapy compared with neoadjuvant chemotherapy in pre-menopausal patients with oestrogen receptor-positive and HER2-negative, lymph node-positive breast cancer

Abstract Introduction Neoadjuvant endocrine therapy (NET) has demonstrated efficacy in post-menopausal patients with hormone-responsive breast cancer. This trial was designed to compare the efficacy of neoadjuvant chemotherapy (NCT) with NET in pre-menopausal breast cancer. Patients and methods In t...

Descripció completa

Dades bibliogràfiques

Autors principals:	Hee Jeong Kim, Woo Chul Noh, Eun Sook Lee, Yong Sik Jung, Lee Su Kim, Wonshik Han, Seok Jin Nam, Gyung -Yub Gong, Hwa Jung Kim, Sei Hyun Ahn
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2020-05-01
Col·lecció:	Breast Cancer Research
Matèries:	Neoadjuvant endocrine therapy Neoadjuvant chemotherapy Pre-menopausal women Breast cancer Clinical response
Accés en línia:	http://link.springer.com/article/10.1186/s13058-020-01288-5
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!